• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Intra-Hospital Spread of Colistin-Resistant Isolates-Epidemiological, Clinical, and Genetic Analysis.耐黏菌素分离株的医院内传播——流行病学、临床和遗传分析。
Medicina (Kaunas). 2024 Mar 21;60(3):511. doi: 10.3390/medicina60030511.
2
Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.比较来自两家伊朗医院的产 OXA-48 碳青霉烯类耐药肺炎克雷伯菌临床分离株的基因组分析
Ann Clin Microbiol Antimicrob. 2021 Oct 23;20(1):74. doi: 10.1186/s12941-021-00479-y.
3
Molecular Mechanisms of Colistin Resistance in in a Tertiary Care Teaching Hospital.多粘菌素耐药在一家三级教学医院中的分子机制。
Front Cell Infect Microbiol. 2021 Oct 26;11:673503. doi: 10.3389/fcimb.2021.673503. eCollection 2021.
4
Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.突尼斯出现耐多粘菌素碳青霉烯酶肠杆菌科肺炎克雷伯菌疫情。
J Glob Antimicrob Resist. 2017 Sep;10:88-94. doi: 10.1016/j.jgar.2017.03.017. Epub 2017 Jul 12.
5
[In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].头孢他啶-阿维巴坦与黏菌素对耐碳青霉烯类肺炎克雷伯菌临床分离株的体外活性
Mikrobiyol Bul. 2022 Apr;56(2):218-229. doi: 10.5578/mb.20229803.
6
Genetic Characterisation of Colistin Resistant Clinical Isolates From North India.印度北部耐粘菌素临床分离株的遗传特征。
Front Cell Infect Microbiol. 2021 Jun 21;11:666030. doi: 10.3389/fcimb.2021.666030. eCollection 2021.
7
Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey.土耳其出现产碳青霉烯酶和多粘菌素耐药肺炎克雷伯菌 ST101 高危克隆。
Acta Microbiol Immunol Hung. 2020 Nov 9;67(4):216-221. doi: 10.1556/030.2020.01275.
8
Carbapenem and Colistin Resistant Klebsiella Pneumoniae ST14 and ST2096 Dominated in Two Hospitals in Turkey.土耳其两家医院中耐碳青霉烯类和多黏菌素的肺炎克雷伯菌 ST14 和 ST2096 占主导地位。
Clin Lab. 2021 Sep 1;67(9). doi: 10.7754/Clin.Lab.2021.201226.
9
Co-occurrence of genes encoding carbapenemase, ESBL, pAmpC and non-β-Lactam resistance among Klebsiella pneumonia and E. coli clinical isolates in Tunisia.在突尼斯,肺炎克雷伯菌和大肠杆菌临床分离株中同时存在编码碳青霉烯酶、ESBL、pAmpC 和非β-内酰胺类耐药基因。
Lett Appl Microbiol. 2022 May;74(5):729-740. doi: 10.1111/lam.13658. Epub 2022 Jan 31.
10
Molecular characterization of colistin resistance genes in a high-risk ST101/KPC-2 clone of Klebsiella pneumoniae in a University Hospital of Split, Croatia.在克罗地亚斯普利特大学医院中,一株高风险 ST101/KPC-2 克隆肺炎克雷伯菌中,对黏菌素耐药基因的分子特征进行了研究。
Int Microbiol. 2023 Aug;26(3):631-637. doi: 10.1007/s10123-023-00327-3. Epub 2023 Jan 23.

引用本文的文献

1
Emergence of and Positive Colistin- and Carbapenem-Resistant in a Bulgarian Hospital.保加利亚一家医院中出现耐黏菌素和碳青霉烯类的大肠埃希菌和肺炎克雷伯菌。
Antibiotics (Basel). 2024 Jul 21;13(7):677. doi: 10.3390/antibiotics13070677.

本文引用的文献

1
Genetic and structural basis of colistin resistance in Klebsiella pneumoniae: Unravelling the molecular mechanisms.肺炎克雷伯菌中多粘菌素耐药性的遗传和结构基础:揭示分子机制。
J Glob Antimicrob Resist. 2024 Sep;38:256-264. doi: 10.1016/j.jgar.2024.06.019. Epub 2024 Jul 17.
2
Roles of crrAB two-component regulatory system in Klebsiella pneumoniae: growth yield, survival in initial colistin treatment stage, and virulence.克雷伯氏肺炎菌 crrAB 二组分调控系统的作用:生长产量、初期黏菌素治疗阶段的存活能力和毒力。
Int J Antimicrob Agents. 2024 Jan;63(1):107011. doi: 10.1016/j.ijantimicag.2023.107011. Epub 2023 Oct 18.
3
Ten golden rules for optimal antibiotic use in hospital settings: the WARNING call to action.医院环境中优化抗生素使用的十大黄金法则:发出 WARNING 行动呼吁。
World J Emerg Surg. 2023 Oct 16;18(1):50. doi: 10.1186/s13017-023-00518-3.
4
Analysis of the prevalence of colistin resistance among clinical strains of ..临床菌株中黏菌素耐药性的流行情况分析
Ann Agric Environ Med. 2022 Dec 27;29(4):518-522. doi: 10.26444/aaem/155253. Epub 2022 Oct 24.
5
Prevalence of Mutated Colistin-Resistant : A Systematic Review and Meta-Analysis.突变型耐黏菌素的患病率:一项系统评价与荟萃分析
Trop Med Infect Dis. 2022 Dec 2;7(12):414. doi: 10.3390/tropicalmed7120414.
6
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 33 种细菌病原体相关的全球死亡率:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21.
7
Global Prevalence of Colistin Resistance in from Bloodstream Infection: A Systematic Review and Meta-Analysis.血流感染中黏菌素耐药性的全球流行情况:一项系统评价与荟萃分析
Pathogens. 2022 Sep 24;11(10):1092. doi: 10.3390/pathogens11101092.
8
Detection of different colistin resistance mechanisms among multidrug resistant Klebsiella pneumoniae isolates in Bulgaria.保加利亚多重耐药肺炎克雷伯菌分离株中不同黏菌素耐药机制的检测
Acta Microbiol Immunol Hung. 2022 Jun 27;69(3):220-227. doi: 10.1556/030.2022.01746. Print 2022 Sep 16.
9
MgrB-Dependent Colistin Resistance in Klebsiella pneumoniae Is Associated with an Increase in Host-to-Host Transmission.肺炎克雷伯菌中依赖MgrB的黏菌素耐药性与宿主间传播增加有关。
mBio. 2022 Apr 26;13(2):e0359521. doi: 10.1128/mbio.03595-21. Epub 2022 Mar 21.
10
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.

耐黏菌素分离株的医院内传播——流行病学、临床和遗传分析。

An Intra-Hospital Spread of Colistin-Resistant Isolates-Epidemiological, Clinical, and Genetic Analysis.

机构信息

Department of Surgery, Military Medical Academy, 1606 Sofia, Bulgaria.

Department of Medical Microbiology, Medical Faculty, Medical University, 1431 Sofia, Bulgaria.

出版信息

Medicina (Kaunas). 2024 Mar 21;60(3):511. doi: 10.3390/medicina60030511.

DOI:10.3390/medicina60030511
PMID:38541237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10972034/
Abstract

appears to be a significant problem due to its ability to accumulate antibiotic-resistance genes. After 2013, alarming colistin resistance rates among carbapenem-resistant have been reported in the Balkans. The study aims to perform an epidemiological, clinical, and genetic analysis of a local outbreak of COLr CR-Kp. All carbapenem-resistant and colistin-resistant isolates observed among patients in the ICU unit of Military Medical Academy, Sofia, from 1 January to 31 October 2023, were included. The results were analyzed according to the EUCAST criteria. All isolates were screened for VIM, IMP, KPC, NDM, and OXA-48. Genetic similarity was determined using the Dice coefficient as a similarity measure and the unweighted pair group method with arithmetic mean (UPGMA). genes and plasmid-mediated colistin resistance determinants (, , , , and ) were investigated. There was a total of 379 multidrug-resistant isolates, 88% of which were carbapenem-resistant. Of these, there were nine (2.7%) colistin-resistant isolates in six patients. A time and space cluster for five patients was found. Epidemiology typing showed that two isolates belonged to clone A (pts. 1, 5) and the rest to clone B (pts. 2-4) with 69% similarity. Clone A isolates were coproducers of NDM-like and OXA-48-like and had -mediated colistin resistance (40%). Clone B isolates had only OXA-48-like and intact genes. All isolates were negative for , , , , and genes. The study describes a within-hospital spread of two clones of COLr CR-Kp with a 60% mortality rate. Clone A isolates were coproducers of NDM-like and OXA-48-like enzymes and had -mediated colistin resistance. Clone B isolates had only OXA-48-like enzymes and intact genes. No plasmid-mediated resistance was found. The extremely high mortality rate and limited treatment options warrant strict measures to prevent outbreaks.

摘要

似乎是一个严重的问题,因为它能够积累抗生素耐药基因。自 2013 年以来,巴尔干地区已报告碳青霉烯类耐药肠杆菌科细菌中令人震惊的多粘菌素耐药率。本研究旨在对当地爆发的 COLr CR-Kp 进行流行病学、临床和遗传分析。所有观察到的 ICU 患者中碳青霉烯类和多粘菌素耐药的肠杆菌科细菌分离株,均来自于 2023 年 1 月 1 日至 10 月 31 日索非亚军事医学院,纳入研究。根据 EUCAST 标准进行结果分析。所有分离株均进行 VIM、IMP、KPC、NDM 和 OXA-48 筛查。使用 Dice 系数作为相似性度量和非加权对组平均法(UPGMA)确定遗传相似性。研究调查了基因和质粒介导的多粘菌素耐药决定因素(mcr-1、mcr-2、mcr-3、mcr-4、mcr-5 和 mcr-6)。共有 379 株多药耐药的肠杆菌科细菌分离株,其中 88%为碳青霉烯耐药。其中,6 名患者中有 9 名(2.7%)对多粘菌素耐药。发现 5 名患者的时间和空间聚类。流行病学分型显示,2 株分离株属于克隆 A(pts. 1,5),其余属于克隆 B(pts. 2-4),相似度为 69%。克隆 A 分离株为 NDM 样和 OXA-48 样酶的共产生者,并具有 mcr-4 介导的多粘菌素耐药性(40%)。克隆 B 分离株仅具有 OXA-48 样酶和完整的 基因。所有分离株均为 mcr-1、mcr-2、mcr-3、mcr-5、mcr-6、blaNDM、blaIMP、blaKPC、blaNDM 和 blaOXA-48 基因阴性。本研究描述了两株 COLr CR-Kp 在院内传播,死亡率为 60%。克隆 A 分离株为 NDM 样和 OXA-48 样酶的共产生者,并具有 mcr-4 介导的多粘菌素耐药性。克隆 B 分离株仅具有 OXA-48 样酶和完整的 基因。未发现质粒介导的耐药性。极高的死亡率和有限的治疗选择需要采取严格措施来预防爆发。